Boston Scientific | BSX - 当期純利益

株価
62.07
毎日の変更
-3.62 -5.51%
毎月
-11.05%
毎年
-39.09%
Q2 予測
60.74




当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
CONMED USD 16.74M 13.88M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Danaher USD 1.03B 168M 2026-03
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Illumina USD 334M 184M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12